AEDESO wants to start a clinical study and launched a crowdfunding campaign to raise the necessary money for it. Patients between 18 and 80 years of...
Minoryx has completed a Phase 3 trial with its drug candidate for a neurodegenerative orphan disease and the results are significant. The only downside is that...
The Generalitat awards Werfen the delivery of reagents at the Vall d'Hebron for up to $959,000 (€791,000). The Barcelona-based company is committed to offer this service...
Starting this year, foreign visitors will face ban from the famous Amsterdam coffee shops. This is not the first attempt by Dutch decision-makers to impose a...
Our Nation's debt to GDP ratio has now climbed above 130%. More importantly, that debt has surged to equal 800% of our entire federal annual revenue....
The Lyon-based company genOway specializing in the design and development of preclinical research models announced on Tuesday, January 19th, consolidated sales of $13.3 million (€11 million)...
The El Roble mining project is located near the municipal seat of Carmen de Atrato (Chocó). Its operation is subway and the metal is considered of...
This is our annual forecast issue. Actually it is more like identifying the themes that dominate and will continue to dominate into the next decade. Forecasts...
Two years ago, the raw materials giant was cast in a bad light when locals in Peru were evicted from their land for the expansion of...
Which mushrooms should you invest in? Psychedelic “magic” psilocybin mushrooms, or the growing functional mushroom phenomenon? With functional fungi like Chaga, Lion’s Mane, and Reishi in...